Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Wearable Microscopes Offer Insight into Inaccessible Spinal Cord Regions

By LabMedica International staff writers
Posted on 22 Mar 2023

In the overall regulation of crucial functions from breathing to movement, the spinal cord acts as a messenger that transmits signals between the brain and the body. More...

However, technology has hindered scientists' understanding on a cellular level of how the spinal cord relays pain signals. Now, scientists have developed wearable microscopes that offer unprecedented insight into the signaling patterns that occur within the spinal cords of mice. This technological breakthrough will significantly improve researchers' understanding of the neural basis of movement and sensations in both healthy and disease contexts, like chronic pain, itch, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS).

The wearable microscopes created by scientists at The Salk Institute For Biological Studies (La Jolla, CA, USA) having a width of approximately seven to fourteen millimeters, comparable to the size of a human spinal cord or little finger, provide real-time, high-resolution, high-contrast, and multicolor imaging of previously inaccessible areas of the spinal cord. The wearable microscope can work in tandem with a microprism implant, consisting of a tiny reflective glass element placed next to the tissue regions of interest.

Utilizing these state-of-the-art microscopes, the scientists sought new information about the central nervous system. Specifically, they aimed to capture images of astrocytes, star-shaped, non-neuronal glial cells, present in the spinal cord. Previous studies conducted by the team indicated that astrocytes play an unexpected role in pain processing. The findings showed that squeezing the tails of mice triggered the activation of astrocytes, sending coordinated signals across spinal cord segments. Such unprecedented visualization of astrocyte activity and any cellular activity in moving animal's spinal cord regions was unachievable before the new microscopes were invented. The team has already kick-started experiments exploring how different pain conditions alter neuronal and non-neuronal activity in the spinal cord and how abnormal cell activity can be controlled by various treatments.

“These new wearable microscopes allow us to see nerve activity related to sensations and movement in regions and at speeds inaccessible by other high-resolution technology,” said senior author Axel Nimmerjahn, associate professor and director of the Waitt Advanced Biophotonics Center. “Our wearable microscopes fundamentally change what is possible when studying the central nervous system.”

“Being able to visualize when and where pain signals occur and what cells participate in this process allows us to test and design therapeutic interventions,” added Daniela Duarte, co-first author of one of the studies. “These new microscopes could revolutionize the study of pain.”

Related Links:
Salk Institute


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.